PFIZER, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.58 USD | -0.76% |
|
-0.28% | -0.73% |
| 12:02am | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
| Jun. 07 | Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 29.73 | 29.73 | 30.50 |
| Spread/Res. | -3.87% | -3.87% | -6.30% |
| Spread/Supp. | +2.92% | +13.14% | +12.52% |
| Support | 27.77 | 25.26 | 25.40 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- PFE Stock
- Charts Pfizer, Inc.
